|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/12 | |
| A61K 47/14 | |||
| A61K 31/485 | |||
| A61K 9/70 |
| (11) | Number of the document | 2640389 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11784951.3 |
| Date of filing the European patent application | 2011-11-17 | |
| (97) | Date of publication of the European application | 2013-09-25 |
| (45) | Date of publication and mention of the grant of the patent | 2014-12-31 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2011/005784 |
| Date | 2011-11-17 |
| (87) | Number | WO 2012/065740 |
| Date | 2012-05-24 |
| (30) | Number | Date | Country code |
| 10014713 | 2010-11-17 | EP |
| (72) |
FLESCHHUT, Jens, DE
FEINAEUGLE, Susanne, DE
LAUER, Karin, DE
|
| (73) |
Hexal AG,
Industriestrasse 25, 83607 Holzkirchen,
DE
|
| (54) | TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING BUPRENORPHINE |
| TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING BUPRENORPHINE |